ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000230.1|Griseorhodin_1 # 3 # 659 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000230.1|Griseorhodin_1 	3	659	+	Loose	300	25.0238	tet(44)	40.0	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTCAAGGTCTGGGGGGTGCACCACGGCGCGGCCGAGGAGCTCGAACGCGCCCTGGACGCGCTCACCGACCTCGCCGGCGTCAAGCCCGCGCACCGCGAGACCACGGCGACGGGGCCCTACGCCGACGTCATGCACGAGGCGCTGTGCGGCTCCAAGACCGTCCAGCAGTGCCACCGCACCGGTACCGGCCCCGAGGCGGTCGGCCACCGGCACCCCTACACCCGGCAGGCGTACCGGCTCACCGGCAGGCCCGTCACCCGCGCCGAGGCCGAGTCCCTGCTGCGGGCGTGGGAGCCCGACCTGGACGCCGAGCACTACCTGCTGTGCATCGCGCTCGGCGGCGCCGCCAACCGGGTCGGCCGCACCGAGACCGCGTACGTGCACCGCGACGCGCGGTTCCTGACCGGATACCAGATCGCCACCCGCGACCCGGAGGCCGTCGCGCGCGGCCCGGTGGAGCTCGACGCGTGGGCCGACCGGTGCGCCGAGGCGCTCGCACCGCTGGCCACGGGCTCGTACATCAACTTCCCCGATTCACGTACGCCGCCCGACTGGGAGGCCGACCACTACGGCGAGAACGCCGCCCGGCTGCGCGCGGTGAAGCGCGCCTACGACCCCGACGGCTTCTTCCGGCACGGCCGGAGCATCGGCTCCTGA	VKVWGVHHGAAEELERALDALTDLAGVKPAHRETTATGPYADVMHEALCGSKTVQQCHRTGTGPEAVGHRHPYTRQAYRLTGRPVTRAEAESLLRAWEPDLDAEHYLLCIALGGAANRVGRTETAYVHRDARFLTGYQIATRDPEAVARGPVELDAWADRCAEALAPLATGSYINFPDSRTPPDWEADHYGENAARLRAVKRAYDPDGFFRHGRSIGS	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	34.06	gnl|BL_ORD_ID|1197|hsp_num:0	1171			1752	1872	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000230.1|Griseorhodin_2 # 718 # 1491 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=7bp;gc_cont=0.753	BGC0000230.1|Griseorhodin_2 	718	1491	+	Loose	450	66.2402	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	28.16	3004045	protein variant model	G93V	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGAAGACAGGACTGACGGACAAGGCGGTGCTCGTCACCGGCGCCTCGCGCGGCATCGGGCGGGCCACGGCCCTCGCCTACGCGGCGGAGGGCGCCCGGGTCGCGATCACCTACCACTCCGACGAGGCCGGGGCGAAGGAGACGGCCGAGCGGGTCGCCGCCGCCGGGGGCACCCCCCACGTCGTCCGCTACGACCTCGGGGACGAGGACTCCGTGCGCTCCGCCGTCGCCTCGGTCGGCGCGGAGTGGGGCGGGGTCGACGTCCTCGTGGCCGGCGCGGTCGAGTGGGGGGAGGCGATTCCGCGCCCCGGACGGAAGATGCCCGCCTTCGAGGAGGTGCCGCCCGCGCAGTGGCAACGGGTCCTGCGCACCTCGGTGGACGGCGTCTTCCACACCGTGCAGGCGGTGCTGCCCCTCATGCGCGACCGGGAGTGGGGCCGCATCGTGGTGCTCGGCGCCGGGCTCGCGGAGACCGGTCTGCCGGGGGCGTCCGCGTACGGGGCCGCGAAGGCCGCCCTGCACGGGCTGGTGCGCAGCCTGGCCTGGGAGGTCGGCCCCGCCGGGATCCTGGTCAACGAGGTCGTGCCCGGCCAGACGCTCACCGAGAACGTCCTCGCACACGCCTCGCCCGCCTTCCTGGAGAACAAGGCCGCCTCCCTGCCCTCGGGCCGCATGAACACGCCCGAGGACGTCGCGCGGGCGATCGTCTTCCTCGGCTCCGCCGCCAACGGGAACATCCACGGCGAGGCCCTGCGCGTCACCGGCGGCCTGTGA	MKTGLTDKAVLVTGASRGIGRATALAYAAEGARVAITYHSDEAGAKETAERVAAAGGTPHVVRYDLGDEDSVRSAVASVGAEWGGVDVLVAGAVEWGEAIPRPGRKMPAFEEVPPAQWQRVLRTSVDGVFHTVQAVLPLMRDREWGRIVVLGAGLAETGLPGASAYGAAKAALHGLVRSLAWEVGPAGILVNEVVPGQTLTENVLAHASPAFLENKAASLPSGRMNTPEDVARAIVFLGSAANGNIHGEALRVTGGL	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	98.09	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	753	triclosan
BGC0000230.1|Griseorhodin_3 # 1488 # 2798 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000230.1|Griseorhodin_3 	1488	2798	+	Loose	400	31.187	Erm(51)	35.19	3007033	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACCCGGCCCCGCTCCCCCGCCCCTTCCGCCCAGCCTCCGCACCCCCAGGAGTTTTCGATGACCGACACACTCGACGAGCCGCAGACGCTGGCGGACGGCGCCGAGGACGCGCCCGCCTACCCCGTCAAACGCACCTGCCCCTACCGGATGCCGCCCGGCTACGAGGAACTCCGGGAGAAGGGCCCCATCTCCCGGGTGACCCTCTGGAACGGACGGACGGCCTGGCTGGTCACCGGCAACGACCTCGGCCGCAGGCTGTTCCCGGACGCCCGGCTCTCCTCGGACGTCCTGGACCCGCGCTTCCCGCTGCTCGCGCCCCGGATCGAGGCGCAGCGGCAGCAGGCCGCCGCGCCGCCGCTGGTCGGCGTCGACGACCCGGTCCACGCCCGTCAGCGCCGCATGGTGCTGCCGAGCTTCGGCATCCGCCAGATCAACGCGCTGCGCCCGGAGATCCAGAAGTACGCCGACGACCTGCTGGACACGATGCTGGCCAAGGGTCCGGGCGTCACCGTCGACCTGCTCACCGAGTACGCGCTACCGATGCCGTCCGCCGTGATCTGCATGCTGCTCGGCGTCCCGTACGAGGACCACCACTACTTCGACGAGCGCTCGCGCCACGTCCTGTCCTCGTCCGGCGAGGAGCAGGCGGCGCAGGCGCAGCAGGCGTTCACCGAGATCCTGGCCTACCTGGACGACCTGATCGTCCGCAAGCAGGCCGAGCCCGGCGACACCCTCCTCGACGAGCTCATCGCCCGCCAGTTGGAGGAGGGCAAGGTCGACCGCCAGGAGCTGGCGATGATCGCCACCGTGCTGCTGGTCTCCGGGCACGAGACGACCTCGAACATGATCGCCCTCTCCACGATGGCGCTGCTGGCCGACCCGGACCAGTTGGCGGCCCTGCGCGCCGACGAGTCCCTGATGCCCCGCGCCGTCGACGAGCTGATGCGGTTCTCCTCCATCGGCGACATGCTGATGCGCGTGGCCAAGGAGGACATCGAGATCGAGGGCCACCTCATCCGGGCCGGCGACGGGGTGATCCTCTCGACCATGCTGATGAACCGCGACCCCGGGGCCTTCGAGCGCCCCGACGAGCTGGACATCCGCCGGCCCGCGGGCCGCCACGTCGCGTTCGGCTACGGCATCCACCAGTGCATCGGGCAGAACCTGGCCCGCGCCGAGATGGAGATCGCGCTGGCCACCCTGTTCCGCCGGGTGCCGACGCTGAAGCTCGCGGTCCCCGCCGAGCAGGTGCCCGTCAACGCGCCGTTCGTCCTCCAGGGAGTCTCCGAACTCCCCGTCACCTGGTAG	MTRPRSPAPSAQPPHPQEFSMTDTLDEPQTLADGAEDAPAYPVKRTCPYRMPPGYEELREKGPISRVTLWNGRTAWLVTGNDLGRRLFPDARLSSDVLDPRFPLLAPRIEAQRQQAAAPPLVGVDDPVHARQRRMVLPSFGIRQINALRPEIQKYADDLLDTMLAKGPGVTVDLLTEYALPMPSAVICMLLGVPYEDHHYFDERSRHVLSSSGEEQAAQAQQAFTEILAYLDDLIVRKQAEPGDTLLDELIARQLEEGKVDRQELAMIATVLLVSGHETTSNMIALSTMALLADPDQLAALRADESLMPRAVDELMRFSSIGDMLMRVAKEDIEIEGHLIRAGDGVILSTMLMNRDPGAFERPDELDIRRPAGRHVAFGYGIHQCIGQNLARAEMEIALATLFRRVPTLKLAVPAEQVPVNAPFVLQGVSELPVTW	MPTYRPNKGRHENGQNYLVNKSMIKKVVDLVPVSASVPVIEIGPGHGALTFPLQDRVLATGGSLTAVEIDPASVRWLEERLRPEVHLYEQDVLDFVLPDGPHVLVGNLPFHLTTAILRHVLHSPGWTHAVFLVQWEVARRRAGVGGATMMTAQWWPWFDFEQHGRIPSTHFRPRPTVDAGVLVMRRREEPLVNWSERARYASFVHAVFTGKGRGIADIVSRVVGRRRERRCAEVLREAGVPANALPKQLDAGQWATLFKAVGR	165.78	gnl|BL_ORD_ID|4752|hsp_num:0	5746			240	393	erythromycin; clarithromycin; clindamycin; azithromycin; pristinamycin IB
BGC0000230.1|Griseorhodin_4 # 2805 # 3008 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000230.1|Griseorhodin_4 	2805	3008	+	Loose	500	22.3274	APH(3')-Vb	28.57	3002650	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGCACCTCTCCGTCGACTCCGACCGCTGCATCGGCTCCGCCCAGTGCGCCGTCACCGTGCCCTCCGTCTTCGAGCAGGACGAGGACGGGCTCTCCACCGTCATCCCCGGCCGCGAGGACGGCGGTGGCGAGCCGATGGTGCGCGAGGCCGTCCGGGCCTGCCCGGTGCAGGCCATCGTGCTGAAGGAGACCGAGGGCGTATGA	MHLSVDSDRCIGSAQCAVTVPSVFEQDEDGLSTVIPGREDGGGEPMVREAVRACPVQAIVLKETEGV	MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLDWLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHELPVSECPFDRRLDVTGEARHNVREGLVDLDDLQEEPAGWTGDQLLAELDLTRPEKEDLVVCHGDLCPNNVLLDPETHRITGLIDVGRLRLATCHADLALAARELAIDEDPWFGPAYAERFLERYGAHHVDQEKMAFYQLLDEFF	25.48	gnl|BL_ORD_ID|1423|hsp_num:0	1548			147	252	neomycin; ribostamycin; paromomycin
BGC0000230.1|Griseorhodin_5 # 3175 # 4134 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.774	BGC0000230.1|Griseorhodin_5 	3175	4134	+	Loose	300	31.187	AAC(3)-Id	32.73	3002529	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGACATACGCAGCCTTGACGGCGACGACCCCGCCACGATCGATCTGCTCCTGCCCGGCTTCCGGGAGACGATGAGCCTCGAACTGCCCGGCGATCCGCCGGTGTCACCCGCGCTGCTGGCCCGGCTGCTGCAACGCCGGCACGGCGCCGACCGGATCGTCCTCGCGGCGTTCGACGGCGACCGGCCGGCCGGCTGCACCAAGCTCGGCCTCGACCTCGGCGTCCCGGACGGGCCCGGCCACGGCTCGCTCTGGGTCTTCCCCGGGTTCCGCCGCCGGGGCGCGGGCACCGCCCTCGTCTCCGCCGCCCGGACCGAACTGCGCGCCCGCGGGCGGGACCTGCTGATGGTCGACGCCCCGCACACCCCGGCCGCCGAGCGCTTCGCCGCCGCCTGCGGGGCCGAGGCGCTGGGCACCAACCTGCGCAACCGGCTCCTCCTCAAGGGGCCCGGCCGCGCCGGGCTCGACGCGGCGGCCGGCCGCGCGGTGCCGGGGCACCGGCTCGTCCACTGGAGCGGCCGCTGCCCCGACGAGCTGGTCGACTCCTACGCCCGTGCCTGGGGCGCCCTGGAGACGGCGGCCAACGGCCAGGCGGCGGTGCGCCGTCCCGCCGCCGCCGACGTACGCGCCCGTGAGGCCGAGGCGGAGCGCGCCGGGCACCGCCCGTACGTGACGGCGGCCGTGGACACGGCCGGCGAAGTCGTGGGCTACGCCACGCTGTTCGTCCGGGACAGCCCGATGGCCGACGCCGGGGAGACCCTGGTCGTCGCCGGCCGGCGGCGCCGGGGGCTGGGCTCCTGGACCAAGGCCGCCCTGCTCTCCCGGGCCGCCGCCGAGAACCCCCACCTCGCGCTGGTGCAGGCGTGGAACGACGTACGCGACGAGGCGTCCCTCGCCCTCAATCGCCGCCTCGGCTTCGTGGGGGACAGCTCCTGGACCACGAACGCCGTCAAGGCGTGA	MDIRSLDGDDPATIDLLLPGFRETMSLELPGDPPVSPALLARLLQRRHGADRIVLAAFDGDRPAGCTKLGLDLGVPDGPGHGSLWVFPGFRRRGAGTALVSAARTELRARGRDLLMVDAPHTPAAERFAAACGAEALGTNLRNRLLLKGPGRAGLDAAAGRAVPGHRLVHWSGRCPDELVDSYARAWGALETAANGQAAVRRPAAADVRAREAEAERAGHRPYVTAAVDTAGEVVGYATLFVRDSPMADAGETLVVAGRRRRGLGSWTKAALLSRAAAENPHLALVQAWNDVRDEASLALNRRLGFVGDSSWTTNAVKA	MSVEIIHLTGNDVALLQSINAMFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDEQKVIGAIAAYELQKFEQQRSEIYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYVQADKGVEDQPAIELYKKLGTIEDVFHFDIAVEQSKNHA	201.90	gnl|BL_ORD_ID|684|hsp_num:0	742			264	429	astromicin; sisomicin; gentamicin
BGC0000230.1|Griseorhodin_6 # 4266 # 5879 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.755	BGC0000230.1|Griseorhodin_6 	4266	5879	+	Loose	550	124.79	Nocardia farcinica rox	35.14	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAGCAGCAGCGGCACACGCGTACTGATCGTCGGTGGCAGCCTCGTCGGCCTGTCCACCGCTGTCTTCCTGGCCCACCACGACGTGCCGGTCACCCTGGTGGAGCGGCACCCCGGCACCTCGATCCACCCGCGCGCGGTCGGCTACTACCCGCGTACCGCCGAGCTGCTGGCCACGGTCGGCGTCGAGGCCCCGGCCAAGGCCGCCGCCTCCGGGTTCGAGAAGCACCGGACCCGCGCGGGCGTGGAGTCCCTGGCGGGCGAAGTGCTGTTCTCCAAGGAGGAGTTGGAGGGCGGGGACGAGCTGGCCGACCTGACCCCGTCCTCCCTGCTGCTGCTTCCGCAGGACCGCCTGGAGCCGATCCTGCGCGCCCGCGCGGAGGAGTTGGGCGCCGAGCTGCGGTTCGGCGCCGAGCTGCGCTCCTTCACCCAGGACGCGGACGGGGTCAGCGCGGTCGTCCGGGACGCGGACGGCGGCGAGAGCGTGGTGCGCGCCGACTACCTGGTGGCCGCCGACGGGCCGCGCAGCACCGTGCGCGAGGCGCTCGGCATCGGCCGGGAAGGACGCGGCGTGCTCTCGCGGCACGTGAGCATCGCGTTCGGCGCGGACTTCGCCGCGGTGCTGGGAGAGCGCCGCTACAGCGTGGTCCACGTCCAGAACGACCGGGTCACCGGCATCCTCGTGCACGACGACACCCTCACCGAGGGCACCCTGATCGTCGGCTACGACCCGGAGAAGGGCGAGGGACTGGACGACTTCACCGACGCCCGGTGCGCGGAACTGGTCTCGGCGGCCATCGGTTCGGACGACGTCGCCGTCACCATCCGCTCCCGCTTCCCGTGGGACATGGCCGAGCTGGTCGCCGACGCGTTCGTCAGCGACCGCGTCCTGGTCGCGGGCGACGCCGCCCACCAGATCCCGCCGACCGGGGGGTACGGCGCGAACACCGGGATCGCCGACGCCTTCAACCTGAGCTGGAAGCTGGCGCACGTCCTCGCGGGCACCGCCGGCCGCGCGCTGCTGGACACGTACGACGAGGAGCGGCGGCCGGTCGGGCTGTACACGGCGCGGCAGGGATCGCTCCAGCTCGCAGTGCGGTCCCGGACCGCGACGGAGGAGCAGCGGGAGGCGGCGCACGACGCGATGCGGGTCACCATGGGGCAGGCGTACCCCTCCGGCGCCTTCGTCGCCGACGCGGGGGCCGATCCGCTGCCGCTGACCTCGGATCCGCGGACGCTGCGCGGCGAGCCGGGCACGCGCGCCCCGTACGTGGTGCTGGAGCGCGACGGCGCCCCGCTGTCCACGCTGGACCTGTTCGGGGACGGCTTCGTGCTGCTGGTCGGGGCCGACGGCGGCTCGTGGGCCGAGGCGGCCGGGGAGGCCGCCGCCGGGCTGGGCGTGGGCATCGCCTTCCACCGCGTCGCGCCGGACGCCGGTGAGGGACGGCCGGTCGACGTGCACGGCCGCTGGGCCGAGGCGTACGGGGTGGGCGCGGCGGGCGCGGTGCTGGTGCGGCCCGACGGGATCGTGGCGTGGCGCAGCCGGGACGGCATGCCGGGCGGGGCAGGGGGCCGCGCGCTCACGGCGGCGCTGCGGACCGTCCTGGCGCGCTGA	MSSSGTRVLIVGGSLVGLSTAVFLAHHDVPVTLVERHPGTSIHPRAVGYYPRTAELLATVGVEAPAKAAASGFEKHRTRAGVESLAGEVLFSKEELEGGDELADLTPSSLLLLPQDRLEPILRARAEELGAELRFGAELRSFTQDADGVSAVVRDADGGESVVRADYLVAADGPRSTVREALGIGREGRGVLSRHVSIAFGADFAAVLGERRYSVVHVQNDRVTGILVHDDTLTEGTLIVGYDPEKGEGLDDFTDARCAELVSAAIGSDDVAVTIRSRFPWDMAELVADAFVSDRVLVAGDAAHQIPPTGGYGANTGIADAFNLSWKLAHVLAGTAGRALLDTYDEERRPVGLYTARQGSLQLAVRSRTATEEQREAAHDAMRVTMGQAYPSGAFVADAGADPLPLTSDPRTLRGEPGTRAPYVVLERDGAPLSTLDLFGDGFVLLVGADGGSWAEAAGEAAAGLGVGIAFHRVAPDAGEGRPVDVHGRWAEAYGVGAAGAVLVRPDGIVAWRSRDGMPGGAGGRALTAALRTVLAR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	113.53	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	978	rifampin
BGC0000230.1|Griseorhodin_7 # 5935 # 6462 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.727	BGC0000230.1|Griseorhodin_7 	5935	6462	-	Loose	270	26.1794	mgrA	27.14	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCTGCCATGGAGACCTCACCCGCCGGGCGGAAGCCCGCGCAGCCGCTGTCCGACAACGGCGCACTGGCCGCCATGGACCCGCTCGACGCGGTGGGCCCCGCCTTCTCGCGACTGCGCCGCGCCTCCGCCCTCAACGCGGAGAGCCCGGTGTCCCGGAAGGACATGACGCGGACGCTGGTGCTCAACATCGTGGACGAGGGGCCCGAGCACGACGGGCAGGAGATCACCGTCGGCGTCGTCGCCGAGCGGCTCGCCGTGGACCCCTCCGTGGCCAGCCGCATGGTCACCGACTGCATCGCCGCGGGCTACCTGATCCGCGCCGCCTCCCAGCAGGACGGCCGGCGCACGATCCTCCAGATGACGGACGACGGGCAGGGCATGCTGGCGGCCTTCCGCCGGCACCAGCGGGCGGCCTTCGAGTTCATCACCCGGGAGTGGCCCGAGGGGGAACGCGAGCAGCTCGCCCGCCTGCTGATCAAGTACGTCGACTCCGTCGCGCAGGCCCGGGGCGCCCTCGACTCCTGA	MSAMETSPAGRKPAQPLSDNGALAAMDPLDAVGPAFSRLRRASALNAESPVSRKDMTRTLVLNIVDEGPEHDGQEITVGVVAERLAVDPSVASRMVTDCIAAGYLIRAASQQDGRRTILQMTDDGQGMLAAFRRHQRAAFEFITREWPEGEREQLARLLIKYVDSVAQARGALDS	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	119.05	gnl|BL_ORD_ID|133|hsp_num:0	154			123	315	methicillin; ciprofloxacin; acriflavine; tetracycline; daptomycin; moxifloxacin; cefotaxime; norfloxacin; sparfloxacin; moenomycin A1
BGC0000230.1|Griseorhodin_8 # 6625 # 8187 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.728	BGC0000230.1|Griseorhodin_8 	6625	8187	+	Loose	600	348.977	Streptomyces venezuelae rox	45.07	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGGACACCAAGGGCACCACCGACACCATCGACACCCCGGGCTTCGACTTCGACGTGATCATCGTCGGCGGCGGCCCCGTGGGCATGCTGCTCGCCTCGGAGCTGCGCATCGGCCGCGCCAAGGCCGTCGTCCTGGAGAAGCTCACCGAGCGCACCCCGCACTCCAAGGCGTTCGGGCTGCACGCGCGGTCGCTGGAGTCGCTCGACCGCCGCGGACTCGCCGACCGCTTCCGCGAGGGCGCCCGCTCCTGGAACAACGGCCACTTCGCGGGCCTCGACGTCTGGGTCGACTTCTCCCTCCTGGACAGCGCCCACAACTACGCCCTGCTGTCCGAGCAGACCCGCACCGAACGACTGCTGGAGGAGCGCGCGGAGGAGTTCGGCTGCACGATCCGCCGCGGCCACGAGGTCACGGCCGTCCGCCAGGACGAGGACGGCGCCGAGGTCGACGTGACCGGCCCCGACGGCCCGTACACCCTGCGCGCCCGGTACGTCGTCGGGACCGACGGCGGCCGCAGCCTGGTCCGCAGGTCGGCCGGGATCGCCTTCCCCGGCACCGGCGGCCGCGTCACCGCGCGGCTCGCCGACGTCGTCCTCGCCGACCGCGAGAACGCCCCCATGGGCATGGAGCGCACCGAGCGCGGCCTGCTCTTCTGCGTACCGCTCGACGACACGTACCACCGCGTCGCCACGTTCGACTACGAGCAGGGCAAGGAGGCGGGCTCCGAGCTCGGCTTCGAGGAGTTCAAGGACAGCGTCCGCGCGATCTGGGGCGACGACATGGGCGCCTCCGAGCCGCGCTGGCTCTCCTGGTTCACCGACTCCGCCTGCCAGGCCGAGACCTACCGCGCCGGCCGGATCCTGCTCGCCGGCGACGCGGCCCACACGCACTTCCCGGTCGGCGGCCAGGGGGTGAACCTGGGCCTCCAGGACGCGCTCAACCTGGGTTGGAAGCTCTGCGCCGACATCAACGGCTGGGCCGGCGAAGGGCTGCTCGACACCTACGACGCCGAGCGCCAGGAGCCCGCGCGTCAGGTCCTGGCCAACACCCGCGCCCAGATCGCGCTGATGAACCCCGACCCCTACGTCACCCAGCTGCGCGAGCTCTTCCAGGACCTCATGCGCAAGGACCAGGTGAACCACCACATCGCCGAGATGCTCAGCGGCGTACGGGTCCGCTACGACCTGCCGGGCCCGGCCCACCGCCTGCTCGGCGACTTCGCCCGCGACCTGCGACTGGAGACGGAGGAGGGGCCCAGGACCCTCCCGAAGTTCCTGCGGCGCGGCAACTTCGTCCTGCTCGACCTGGCCGGACGGCCGGAGATCGCGGAGGAGTACGCGAAGTGGGCCGCGCCGCTCGACTGGGCCGGGCGCGTCCGGCATCTCGTCGCCACGTGCGAGGACGAGCCGGAGCTGGCCGGCGCCCTCATCCGCCCGGACGGCTACGTGGCCTGGGCCGCCGACCGCGACGCCTCCCCCGCCGAGATCGCGGAGGGGCTGCGGACGGCGATCGAGACCTGGGCCGGGATCACCGACCCGACCCGCGCGGTCTTCAGCTGA	MPDTKGTTDTIDTPGFDFDVIIVGGGPVGMLLASELRIGRAKAVVLEKLTERTPHSKAFGLHARSLESLDRRGLADRFREGARSWNNGHFAGLDVWVDFSLLDSAHNYALLSEQTRTERLLEERAEEFGCTIRRGHEVTAVRQDEDGAEVDVTGPDGPYTLRARYVVGTDGGRSLVRRSAGIAFPGTGGRVTARLADVVLADRENAPMGMERTERGLLFCVPLDDTYHRVATFDYEQGKEAGSELGFEEFKDSVRAIWGDDMGASEPRWLSWFTDSACQAETYRAGRILLAGDAAHTHFPVGGQGVNLGLQDALNLGWKLCADINGWAGEGLLDTYDAERQEPARQVLANTRAQIALMNPDPYVTQLRELFQDLMRKDQVNHHIAEMLSGVRVRYDLPGPAHRLLGDFARDLRLETEEGPRTLPKFLRRGNFVLLDLAGRPEIAEEYAKWAAPLDWAGRVRHLVATCEDEPELAGALIRPDGYVAWAADRDASPAEIAEGLRTAIETWAGITDPTRAVFS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	109.24	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	1371	rifampin; rifaximin; rifapentine
BGC0000230.1|Griseorhodin_9 # 8233 # 9360 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=5bp;gc_cont=0.705	BGC0000230.1|Griseorhodin_9 	8233	9360	+	Loose	660	144.05	MexS	30.36	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGGGACGCCGCGCGTAAGGGACTGGCAAAGAATCCCCGCATCCCCCATAAAATGTGGACCGACAATCAAATGCATGCAAGCATGCATACGTTGCTTCCGAGCCCCAGCGATCCGCGACGGCTCGACCGAACCCCGTTGGGAGAAAACATGCGCATCGTCCGCCACTACGAGCACGGCGCGCCGTCCGTGCTGCGCCTCGAAGAGGTGGAGAAGCCGCAGCCCGGCCCGGGTCAGGTCCTGATCCGTGCCGAGGCCATCGGCGTCACCTTCGCAGAGGTCCAGCGCCGCCAGGGCATTCCGATCGGCGGCCACGCCGGGCTCCCCGGCGCCCCCGGCGGCGATGTCGCGGGCACCGTCGAGGCGCTCGGCGAGGGCGTCACCGGCTTCGCCGTCGGCGACCGCGTCGTCGGCGACGTCGACCGGGACGCCTACGCCGACTACGTCGTCACCGGCACGGACTGGCTCATCAAGATCCCGCAGGACCTCGACGCCGCCGCGGCGACCCTGCTCCCGAGCCCGGCCCAGACCGCGTACCACGCGATCAAGGAGGCCGGCCGCCTCCGGCCCGGCCAGAGCATCGTGATCGACGCGGCCTCCGGCGGCGTCGGCCACCTGGCCGTCCAGATCGCCAAGGCCCTCGGCGCCGGCAAGGTCATCGCGACCGCGAGCACGCAGGCCAAGCTCGACTTCGCCCGCGAACTCGGCGCCGACGTCACCGTCAACTACACCGACGAGGACTGGACCGACCAGGTCCTCGCCGCCACCGACGGGCGCGGGGCCGACATCGTCCTGGAGACCGTCGGCGGCGACGTCCTGCTCAAGTCGCTCGGCATCACCGCCCAGTTCGGGACGCTCGTCTTCTACGGTTCGGCCTCCGGCGACATCCCGGACCTGCCCACCCTCGCGCTGTCCCGCATGAAGAACGTCGCGGGCTTCAGCCTCTACGCCATGCTCTACAACAAGCAGGACGCCGTGGCCGAGGGGCAGCGCCACCTGCTCGACCTCATCGCCTCCGGCGAGGTCAAGCCCGTCGTGCACGACCGGCTGCCGCTCGACGAGGCGGTCAAGGCCCACGAGTTGCTGGAGGCACGGGCCCAGCTCGGCAAGATCGTCCTCGTTCCCTGA	VRDAARKGLAKNPRIPHKMWTDNQMHASMHTLLPSPSDPRRLDRTPLGENMRIVRHYEHGAPSVLRLEEVEKPQPGPGQVLIRAEAIGVTFAEVQRRQGIPIGGHAGLPGAPGGDVAGTVEALGEGVTGFAVGDRVVGDVDRDAYADYVVTGTDWLIKIPQDLDAAAATLLPSPAQTAYHAIKEAGRLRPGQSIVIDAASGGVGHLAVQIAKALGAGKVIATASTQAKLDFARELGADVTVNYTDEDWTDQVLAATDGRGADIVLETVGGDVLLKSLGITAQFGTLVFYGSASGDIPDLPTLALSRMKNVAGFSLYAMLYNKQDAVAEGQRHLLDLIASGEVKPVVHDRLPLDEAVKAHELLEARAQLGKIVLVP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	110.62	gnl|BL_ORD_ID|1039|hsp_num:0	1041			6	1005	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000230.1|Griseorhodin_10 # 9589 # 11178 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0000230.1|Griseorhodin_10 	9589	11178	+	Loose	950	233.032	tcr3	34.24	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCGCTCCCACTCCCCCGGCCCCCGGGGGCCCGCACCCCTCCGGCACCAGGACCACCCCGGTCATGGTCGCCTGCATGCTCTCCGCGTTCGTGGCCATCCTCGACCTGCAGATCGTCTCCACCGCCCTGCCCCGCATCGCGGGCGACCTCGGCGGCATCGACCTCTTCGCCTGGGTGACCATCGCCTACGTCATCGCCTCCAGCGTCACCACGCCGATCTACGGCAAGCTCGGCGACCTCTTCGGCCGCAAGGTCACCTACCTCTCGGCCATGGGTCTGTTCCTGCTCGGCTCCGCGCTCGCGGGCGCCGCCGGCAGCATGGAGCAGCTCATCGTCTTCCGCATCGTGCAGGGGCTGGGCGCCGGAGGGCTGTTCGTCTCCGTCCTCGCGATCATCGGCGAGCTGTTCACCCCGCGCGAGGGCGCCAAGTACTACGGCATGTTCGGCATGGTCTTCGCCGGCGCCTCCCTGGCCGGCCCGGCCGTGGGCGGTCTGCTCACCGACGCGCTCAGCTGGCACTGGGTCTTCCTGGTCAACCTCCCCGTCGGCGCCGTGATCGTCGCCCTGCTGGTCAAGTACCTGCACCTGCCCCGGAAGGCCGCCGCGGGCGCCAAGCTCGACTACGCGGGCATCGTCACGCTCTCCGCGGCCATCATCGCCCTCACCCTGCTCACGTCCTGGGGCGGCGTCGAGTACGCCTGGACCTCCCCGCAGATCATCGGGCTCGGCCTCGGCACCCTGGTCTTCCTCGGACTGTTCGTGAAGGCCGAGTCGACCGCCTCGGAGCCGATCGTCCCGCTGCGCCTCTTCCGGGACTCCACCTTCACCATCTCGCTGCTCGGCACCACCGTCTGCGGCATCGTCTTCGTCGGCGCGGTCCAGTTCCTCGCCCTGTACGTCCAGGTCGCCACCGGCGCCAGCCCCACCGCCTCCGGCTTCATCCTGCTGCCGATGATGATGGGCCTCGTGCTCTCCTCCGTGGGGTCGAGCCGGATCATCATGAAGACCGGCACGTACAAGATCTTCCCGATCCTGAGCATGGCGCTCGGCATCGTCGGAGCCCTCCTGCTGTCCACCATGGACTCGGACACCCCGCGCGTGCTCACCATCCTCTACATGGTGGTCTTCGGCTTCGCCTCGGGCCTCTCGGCCCAGGTGTTCACGCAGGCGGCCCAGAACACCGCGCCCCCGCAGGACATGGGCGCCGTCTCCGGCACCGTGACCTTCGGCCGCTCCTTCGGCACCTCGATCGGCATCTCGCTCTTCGCGGCCGTCTTCTACGGACGGCTCACCGACGAACTCGCCGCCCGGGTGCCGGACGGCGCCCTCGACGGCATCGACCGCAACTCGCTCTCCTCGGACACCGTCCTCGCCACCCTCGCGGACCCGGTGCGCGGCGCCGTCGAGGACGCGTACGCGGCCTCGCTCACCCCGGTGTTCACCACCGCCGTGCCGATCCTCGCGGTGGGCCTGGTCCTCACCCTGCTCATGAAGAACCTCACGCTCCGCTCCCGCCACCACGGCGCCGACGAGCCGGCCGAGAGCCCGGCGCCGGCCGCCGCCGACGGCACCCCCGAGACGGCCTGA	MSAPTPPAPGGPHPSGTRTTPVMVACMLSAFVAILDLQIVSTALPRIAGDLGGIDLFAWVTIAYVIASSVTTPIYGKLGDLFGRKVTYLSAMGLFLLGSALAGAAGSMEQLIVFRIVQGLGAGGLFVSVLAIIGELFTPREGAKYYGMFGMVFAGASLAGPAVGGLLTDALSWHWVFLVNLPVGAVIVALLVKYLHLPRKAAAGAKLDYAGIVTLSAAIIALTLLTSWGGVEYAWTSPQIIGLGLGTLVFLGLFVKAESTASEPIVPLRLFRDSTFTISLLGTTVCGIVFVGAVQFLALYVQVATGASPTASGFILLPMMMGLVLSSVGSSRIIMKTGTYKIFPILSMALGIVGALLLSTMDSDTPRVLTILYMVVFGFASGLSAQVFTQAAQNTAPPQDMGAVSGTVTFGRSFGTSIGISLFAAVFYGRLTDELAARVPDGALDGIDRNSLSSDTVLATLADPVRGAVEDAYAASLTPVFTTAVPILAVGLVLTLLMKNLTLRSRHHGADEPAESPAPAAADGTPETA	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	103.32	gnl|BL_ORD_ID|592|hsp_num:0	652			135	1524	tetracycline
BGC0000230.1|Griseorhodin_11 # 11381 # 12412 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0000230.1|Griseorhodin_11 	11381	12412	+	Loose	400	28.1054	Erm(30)	27.38	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACAACGACCGATGACCGTACGACGGCCGCGGCGGTCGACCCCGGTCCGCTGATCAAGCTGACCATCGCGGACTGCGCGGCGAAGGTGCTGCACAGCGCGGTGGCGCTCGGGGTGTTCGGCGCCCTCGCCGACGGCCCGGCCGACGCGGACCAGGTCGCCGCCGCGACCGGCCTGCACGAACGCATGGCCCCCGACTTCCTCGACGCGCTGGCCGGCCTGGGCCTGCTGGAGCGCACGGGGGACCGGTACGGCAACAGCCCGCTGGCCGAGGCGTACCTCGTGCCGGGCACCGCGACGTATCTGGGCGGCTTCGTCGAGCTGACCAACGAGACCCTGTACGGCACCTGGGGGCGGCTGACCGAGGCGCTCACCACCGGGGCCCCGCAGCACCTCGACCCCGACAAGGGCGGCTTCGTCGGCGACCGGCACAAGGACCCGGAGAAAATGAAGCGGTTCTTCGCGGGCCTCGACGCCTACAGCGACCGCATGGGCGTCGAGATCGCGCGCGCCGTCGACTGGAGCCGCCACACCTCCTTCACCGACCTCGGCGGCGCGCGCGGCAACCTGGCCGCCGTCCTGGTCAAGGAGCACCCGCACCTCACGGCCGGGGTCTTCGACCTGGAGCGCACCCGCCCGCTCTTCACCGAGCACACCACCCGCCTCGGGCTCGACGGCCGCGTCGCGTTCACCGGCGGCGACTTCTTCACCGACGACATCCCGAAGGCCGACGTCATCGTGCTCGGCCACATCCTGCACGGCTTCGGCACCGACCGCCGCCGCGAACTGCTGAACCGCGTCTTCGCCGCGGTCAACCCCGGCGGCCGGGTGCTCGTCTACGACCGGATGATCGACGACGAGCGCCGCGATCCCGAACGGCTGCTCTCCAGCCTGCACATGCGCCTGGTCAGCCAGGACGGTTCCGAGTACCGCGTCGGCGACCTGCGCACCTGGCTCGCCGGGGCCGGATTCGCCGACAGCACCGCGCAGCCGCTGCTGGGCACGCACACGCTGGTCACCGCCGTCCGATGA	MTTTDDRTTAAAVDPGPLIKLTIADCAAKVLHSAVALGVFGALADGPADADQVAAATGLHERMAPDFLDALAGLGLLERTGDRYGNSPLAEAYLVPGTATYLGGFVELTNETLYGTWGRLTEALTTGAPQHLDPDKGGFVGDRHKDPEKMKRFFAGLDAYSDRMGVEIARAVDWSRHTSFTDLGGARGNLAAVLVKEHPHLTAGVFDLERTRPLFTEHTTRLGLDGRVAFTGGDFFTDDIPKADVIVLGHILHGFGTDRRRELLNRVFAAVNPGGRVLVYDRMIDDERRDPERLLSSLHMRLVSQDGSEYRVGDLRTWLAGAGFADSTAQPLLGTHTLVTAVR	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	102.08	gnl|BL_ORD_ID|1123|hsp_num:0	1224			138	375	narbomycin; methymycin; pikromycin
BGC0000230.1|Griseorhodin_12 # 12458 # 14062 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000230.1|Griseorhodin_12 	12458	14062	+	Loose	550	143.665	Nocardia farcinica rox	31.3	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCCAGGAGAACGTGCCCGTCCTCATCGTCGGCGGTGGCCTGACCGGGCTGTCCGCCGCCGTGTTCCTCGCCCACCACGGGGTGCGGGCCACGCTCGTCGAGCGCCACCCCGGCGCCTCCACCCACCCCAAGGCGCGGGCCATCAACCCGCGCACCATGGAGCTCTACCGCGCGGTGGGCATGGAGGAGCGCGTCACGGCCGGCCGTTCGCCGATCTCCGGCAACACCGACCTGGTGCACGTCGAGACCCTCGCCGGCGCCGAGCGGGTCCGCATGCCCAACGCCTCCGTCGAGGACATCAGCCGCATCAGCCCGGCCCGGTGGACCCTGATCGACCAGAACCAGCTCGAACCCATCCTGCGCGCACGGGCCGAGGAGGTCGGCGTCGACCTGCGCTTCCACACCCGGCTGGACGCCGTCACCGAGACCGCCGACGGCGTCACCGCGACCCTCACCGACGTCGGGACCGGCGGTAGCACCGAACTGCGCGCCGCGTACGTGATCGCCGCGGACGGCAGCCGCAGCCCGGTCCGCGACCTCCTCTCCATCGGCTCCCACGGCCGCGGCACCCTCACCAACCTGGTCAGCTTCTTCTTCGACGCCGACCTGGAGGAGCCGCTGCGCGGCCGGAAGATCATCGCCGCCTACGTCAACAACCCCGAGGTGCGCGGCACGATCATCCCGCTCGACAACGACCGCAAGTGGGTCATCAACGTCTCCTTCTTCCCCGACAAGGGCCAGAGCGCCGAGGACTTCACCCCGGAGCGCTGCGTCGAACTGGTCCGCGCCGCCGTCGGCGTACCGGATCTGGAGCTGACCCTCGACTCGGTCGACATGCCCGCCTGGGACATCTCTGCGCGGGTGGCGGACACCTTCGCCCGCGGCCGCTTCCTGGTGGCCGGGGACGCCGCGCACGTGATGCCGCCCACCGGGGCCTTCGGCGCCAGCACCGGCATCCAGGACGCCTACAACCTGGCCTGGAAGCTCGCCCTCGTGCTGGCGGACAAGGCCGGGCCCGAGCTGCTCGCGAGCTACGACGCGGAACGCCGCCCGGTCGCGGAGGAGACCGTCCGGCAGGCGATGCTGCGGTTCGCGGTCCGCGAGGGCAAGCAGTTCCAGGACGTCGCCAAGGACCTGGTCGACGAGATGACGATGACCTTCGGCTACGTCTATCCGGCCGGCGCGTTCACCGGCGAGGGCGCCGGGGCCGGGAACATCACCGAGGAGCCCGACAAGCCGAGCGGCCGCCCCGGCGCACGGGCCCCGCACGTCGTGATCGAGGGCGCGCACGGGCCGTTCTCCGCGGTGGACCTCTTCCCGGTCGGCTTCACCCTGCTCACCGCGGGCGCGTCCGCCCCCTGGGCGGCTGCGGCCGACGCGGGCCGGGAGCTGGGCCTGGTCCTCCAGGTGCGCGGCGTCGGCGCGGGCGGCGACTACGCCGACACCGAGGGCACGTTCACGGAGCGCTACGGCGTCGCGGACGGCGGCGCGGTCCTGGTCCGCCCGGACGGGGTGGTCGCCTGGCGCGCCGGGAGCGCCCCCGAGGGCGATGTCGCGGCGACGGTGACGGGCGTCCTGCGGCGGATCCTCGCGCTGGACTGA	MSQENVPVLIVGGGLTGLSAAVFLAHHGVRATLVERHPGASTHPKARAINPRTMELYRAVGMEERVTAGRSPISGNTDLVHVETLAGAERVRMPNASVEDISRISPARWTLIDQNQLEPILRARAEEVGVDLRFHTRLDAVTETADGVTATLTDVGTGGSTELRAAYVIAADGSRSPVRDLLSIGSHGRGTLTNLVSFFFDADLEEPLRGRKIIAAYVNNPEVRGTIIPLDNDRKWVINVSFFPDKGQSAEDFTPERCVELVRAAVGVPDLELTLDSVDMPAWDISARVADTFARGRFLVAGDAAHVMPPTGAFGASTGIQDAYNLAWKLALVLADKAGPELLASYDAERRPVAEETVRQAMLRFAVREGKQFQDVAKDLVDEMTMTFGYVYPAGAFTGEGAGAGNITEEPDKPSGRPGARAPHVVIEGAHGPFSAVDLFPVGFTLLTAGASAPWAAAADAGRELGLVLQVRGVGAGGDYADTEGTFTERYGVADGGAVLVRPDGVVAWRAGSAPEGDVAATVTGVLRRILALD	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	112.90	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	1116	rifampin
BGC0000230.1|Griseorhodin_13 # 14303 # 15892 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.738	BGC0000230.1|Griseorhodin_13 	14303	15892	-	Loose	550	150.599	Nocardia farcinica rox	35.53	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGCGGAGCGAACCGACGTACTGATCGTGGGCGGCAGCATGGTGGGCCTCGCCCAGGCCCTGTTCCTCGCCCAGCAGGGCATCCGGTCGATCCTGGTGGAGCGCCATACGCACATCTCGGCGCACCCCCGGGCCCAGGCGGCCAGCCCCCGCACGATGGAGCTGATGCGCGCGCTGGGGCTGGAGCAGAAGGTGCGCGCGCGGGAGAACCCGCACGCGCAGTACGGCGACATCCTCCAGGTGGAGTCGCTGACGGGCCGTGAACTGGGCCGGTTCGACGGGCCGTTCCGGCACGACCCGAACGAGGTGAGCACGACCGGCTGGACCCTGATCGGCCAGGACCGGTTCGAGCCCGTGCTGCGCGCCAAGGCCGAGGAGCTGGGCGCGGACATCCGGTTCGCCACCGAGATGGTGTCCTACGAGCAGGACGCCGACGGGGTCACCGCGGTGCTGCGGGACGTGCGCGGGGGAGAGGAGACCGAGGTCGAGGCCGCGTACCTGGTCGCGGCGGACGGCTTCCGCAGCACCGTCCGCGACGGACTGGGGATCGGCACCCACGGACAGGGCGTCTTCGGCCGCCAGATGAACGTCATCTTCCACGCCGCGCTCGACCCGTACGTTGCGGAGCGCCGGTTCTTCCTCTGCTTCGTCAGCAACGACCGGGTCAAGGGCGTCCTCGGCCGGCTCGACGACGGGGACCGCTGGGTGCTGGCTCCGAGCCTGCCGCCCGAGAAGACGCACGCCGCGTACTCCGAGGAGGACTGCGTCGCCATGGTGCGCGCCGCGGTCGGCGTACCGGACCTGGACGTGGCCGTGGAGTCCAGCACGAGCTGGGAGGTGGCCGCCCGGATCGCCGACCGGTTCCGTTCGGGACGGGTGTTCCTGGCCGGTGACGCGGCCCATGTGATGCCGCCCACCGGGGGGTTCGGCGGCAACATGGGGGTGCAGGACGCGCACAACCTGGCGTGGAAGCTGGCGGCGGTCCTGCGGGGGCAGGCGGGCCCCGCCCTGCTGGACACCTACGAGGAGGAGCGCGTCCCGGTCGCGGAGTTCACCGTGGAGCAGGGCGTCATCCGCTATCTGCAGCGCAGCGGTCTGGACGAGGAGGTCGCGGCCCGCCACCGGCCGGAGACCACGGTGCTGTTCGGCCACGTCTACCGCTCGGGCGGGGTGCTGGCGGAGTCCGGCGGCGAGGACGGCCCCCCGGTGGAGGACCCGACCCAGCCGTCCGGCCGCCCCGGCGCCCGCGCGCCCCACGTCGAGCTGCGCGTCGGCGGTGTGGACACCCCGCTGCACGACCTGCTCAGGGGCGGCTGGTGGCTGCTGGCCGGCCCGGACGCCGGGCTGTGGGAGCGGGCGGCCGCCCAGGTGTCCCGGCTCACCGGCCTCGTGGTCGACTTCCACCGGGTGGGCGGTGAGGAGCCGGTCGAGACAGTCGAGGGCTTCCTGAAGAAGTACGGCATCACGACCGGCGGCGCGGTCCTGGTCCGCCCGGACGGGTTCGTCGCCTGGCGCGCGGCCGGGCAGCCGGCGGACCCGGCGGTCGAACTCTCGGCGGTCGTCCACCGGTTGCTGGGGCGCCCGGCCTGA	MAERTDVLIVGGSMVGLAQALFLAQQGIRSILVERHTHISAHPRAQAASPRTMELMRALGLEQKVRARENPHAQYGDILQVESLTGRELGRFDGPFRHDPNEVSTTGWTLIGQDRFEPVLRAKAEELGADIRFATEMVSYEQDADGVTAVLRDVRGGEETEVEAAYLVAADGFRSTVRDGLGIGTHGQGVFGRQMNVIFHAALDPYVAERRFFLCFVSNDRVKGVLGRLDDGDRWVLAPSLPPEKTHAAYSEEDCVAMVRAAVGVPDLDVAVESSTSWEVAARIADRFRSGRVFLAGDAAHVMPPTGGFGGNMGVQDAHNLAWKLAAVLRGQAGPALLDTYEEERVPVAEFTVEQGVIRYLQRSGLDEEVAARHRPETTVLFGHVYRSGGVLAESGGEDGPPVEDPTQPSGRPGARAPHVELRVGGVDTPLHDLLRGGWWLLAGPDAGLWERAAAQVSRLTGLVVDFHRVGGEEPVETVEGFLKKYGITTGGAVLVRPDGFVAWRAAGQPADPAVELSAVVHRLLGRPA	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	111.84	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	981	rifampin
BGC0000230.1|Griseorhodin_14 # 16209 # 16658 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.709	BGC0000230.1|Griseorhodin_14 	16209	16658	+	Loose	750	25.7942	mdtH	29.51	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGAAACCCTGAGTGTGCTGGTGCTGTTGGGCACCGGCCTGGTGGCGGGGGTGCTGTTCGCCGTGGCGGTCAGCGTCATGCCCGCCCTGATCGCGATGGAGCCGGAGCGCTACGTCGACACGCACAAGCTGCTCGGCAAGCGGTACGACCGCATCATGCCGTTCATCGTGAGCGGCTCCGTCGTCATCGACGCGGCCTTCGCCGTGCGGGCGGACGCGACCGGGCCGCGAGTGCTGTTCATCGCCGCCGCCCTGGCCATGACCGGGGTCGCCGTCGTCTCGCAGACCCGCAACGTGCCCATCAACAACCGGGTCAAGAAGACGCGGCCCGACGAGCTCGGGCCCGGCTGGGAGGACCCGCGCGGCCAGTGGCGGGACTGGCATCTGCTGCGCACCTGCTTCGCCGTCGCCGGCTGCTCCCTGACCGCCGCCGCGGTGGTGCTGTCATGA	METLSVLVLLGTGLVAGVLFAVAVSVMPALIAMEPERYVDTHKLLGKRYDRIMPFIVSGSVVIDAAFAVRADATGPRVLFIAAALAMTGVAVVSQTRNVPINNRVKKTRPDELGPGWEDPRGQWRDWHLLRTCFAVAGCSLTAAAVVLS	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	37.06	gnl|BL_ORD_ID|342|hsp_num:0	375			228	402	enoxacin; norfloxacin
BGC0000230.1|Griseorhodin_15 # 16655 # 17236 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.773	BGC0000230.1|Griseorhodin_15 	16655	17236	+	Loose	450	26.5646	ANT(4')-Ib	43.75	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGAGCGCCGGCACCGGAACGGGCGGCCGTGCCGCAACGGGCGGCGGCACCGGAAGGAGCGCCGACGCCGGAACGGGTCTCCCGGTCATCTCCCGGGTCCTGCCGCCCGTCGCGGAACGGGCCGCCGCGAACGCCCGCATGGTCGCCCTGCTGACCGGCCCGGAGCCCGGCCCGGTCGCCGAGCACCTGGCCCTGCTGCACTTCACCGGTCGGCGCAGCGGCGCGGCGCACACCGTCCCGGCGGGCCTGCACCGCGTCGGGGGCGGGCTGTTCGTCGCCACCGGCAGCCCCTGGCGGCACAACTTCGCCGGCGGGGCGCCCGGCGAGATCACCTGGCGCGGCAACCGCTCCCCCGTCCGCTTCACGCTGGTCACCGACGGGGAGCGGACCGCCCGCGGCTACCACGAGCTGTACGAGCGCTACGGCCCCGAGGCCGCCCAGCGCCGCCTGGGCATCACCGTGGACGCCGCCGCCACGCCCACCCCGGCCGACTTCCGGGCCGCCGTCACCGGCATCCCGCTCGCCCTGGTGGCCGTGGACCTCCTGACCGCATCCGTCACGAACGAGAGGACCTCCCGATGA	MSAGTGTGGRAATGGGTGRSADAGTGLPVISRVLPPVAERAAANARMVALLTGPEPGPVAEHLALLHFTGRRSGAAHTVPAGLHRVGGGLFVATGSPWRHNFAGGAPGEITWRGNRSPVRFTLVTDGERTARGYHELYERYGPEAAQRRLGITVDAAATPTPADFRAAVTGIPLALVAVDLLTASVTNERTSR	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	75.39	gnl|BL_ORD_ID|2143|hsp_num:0	2383			339	426	dibekacin; amikacin; tobramycin; isepamicin
BGC0000230.1|Griseorhodin_16 # 17233 # 19110 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000230.1|Griseorhodin_16 	17233	19110	+	Loose	900	29.6462	iri	38.46	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCGCAATCGCCGGCTGGGTCGACTTCGAGCGGGACCTGTCCCCGCAGGCCGCGACCGTCGAGACCATGGCGGCCGCCCTGGCCCACCGCGGCCCGGACGGCCGGGGCGTCTGGGCGGAGGGGCACGCCGCCCTCGCGCACCGGCGCCTGGCCCTGCTCGACCTGACGGAGACCGGCGCGCAGCCGGCCGTCCACACCACCGAGGGGGGCGCCGCCGTCGCCGTCCTCACGCTCGACGGAGCGCTGACCAACCACACCGAGCTGCGGGCCCGACTGGCCGCGAAGGGCCACCGGTTCACCGGCCGGGGCGACGGCGAGACCGCCCTGCACGCCTATCTGGAGTGGGGGGCGGACTTCCTCACCCGCCTGGAGGGCCTGTTCGCGATCGCGGTGTGGGACGTACGCCGTCAGGAGCTGCTGCTGGCCCGCGACCGCCTCGGCGTCAAGCCGCTGAGCTACCACCCGACGCCCACCGGGGTCCTGTTCGGGTCCGAGCCCAAGGCGATCCTGGCCCACCCGGACGTCGACGCGGTCGTCGACGCCGACGGGCTGCGCGAGCTGTTCGCACACAGCCGCAAGCCGGGCACCGGCGTCTTCCGGGGGATGCGCGAGGTCGTCCCCGGTCACGCGCTGATCGTCCGTCGCCCCGGCAGCCGGGAGCAGCGGTACTGGTCGCTGCCCGCGCGGGAGCACACCGACAGCCTCGACACGACCGTCGCCACCGTGCGCGGCCTGCTCGCGGACGCCGTCGCCTCCCACACGCGCGCCGACGCCCCGGTGGGCGCCATGCTCTCCGGCGGCATCGACTCCAGCGCCCTGAGCGCCCTCGCCCACCGCGACCTCACCGCCGCCGGCTCCGGCCCGCTGCGCACCTTCTCGGTCAACTTCACGGGGTACACCGAGAACTTCGAGCCCCACCCCACGATGCGCTCGACGCCCGACGCCCCGTTCGCGGCCCTCGCCTCGCGGCACATCGGCTCCCGGCACACCGAGTTCCTGCTGGACACGGCCGCCCTCACGGACCCCGGGGTGCACACCGCCGCCCTGCGCAGCCAGGACGCCCCCTCGCCGCTCGGCGACATGGACGTCTCCCTCCTGCGGTTCTTCGCCCGGCTGCGCGAGGAGGGGTTCGCGGCCGTGCTCTCCGGGGAGACCGCCGACGAGGTCTTCAACGGCTACTTCTGGGCGTACGACCCGAAGCACAGCAACTCGCAGACCTTCCCCTGGGTCTCCTTCGAGCGCGGCCACGACGCCGCGGCCGGCGGTCTCGGCACCTCGATGATCGACCGCGAACTGCGCAAGCGGCTGGACTTCCTGGGCTACGCGGACCAGCACTACCGGGACGCCCTCACCGAGGTCCCGCACGTCGACGGGGACACCGCGGCCGAACGCCGGGCTCGCGAGGTCACGTATCTCGCGCTGACCCGCTGGGCCCCCACCCACCTGGACCGCGCCGACCGCATGAGCATGGCGCACGGCGTCCAGCTCCGGCCGCCCTTCTGCGACCGGGCGCTCGTCGAGTACGTCTACAACGTGCCGGCCGCCATGAAGCGGGTGGACGGCGTCGAGAAGAGCCTGCTGCGCTCCGCCGTCGCCGACCTGCTGCCCGACGAGGTCCTGCACCGCCGGAAGAGCGCCTACCCCACCACCCAGGAGGCGGCCTACGGCGACTTCGTGCGCCAACGGTTCGCCGAGCTGGCCGCCGACCGGGACGCGGCCGTGGCCGAGTTGCTCGACACCACCGCCACCGCCGAGGCGGTGGCCGCCGACGGCTCCCCGCAGGGCGCCTTCGCCTGGGTCGAGCGGGCCGGCATGGAGATGGCGCTCCAGCTCGACACCTGGCTCACCGACTACCGGGTCGACCTGCGGCTCTGA	MSAIAGWVDFERDLSPQAATVETMAAALAHRGPDGRGVWAEGHAALAHRRLALLDLTETGAQPAVHTTEGGAAVAVLTLDGALTNHTELRARLAAKGHRFTGRGDGETALHAYLEWGADFLTRLEGLFAIAVWDVRRQELLLARDRLGVKPLSYHPTPTGVLFGSEPKAILAHPDVDAVVDADGLRELFAHSRKPGTGVFRGMREVVPGHALIVRRPGSREQRYWSLPAREHTDSLDTTVATVRGLLADAVASHTRADAPVGAMLSGGIDSSALSALAHRDLTAAGSGPLRTFSVNFTGYTENFEPHPTMRSTPDAPFAALASRHIGSRHTEFLLDTAALTDPGVHTAALRSQDAPSPLGDMDVSLLRFFARLREEGFAAVLSGETADEVFNGYFWAYDPKHSNSQTFPWVSFERGHDAAAGGLGTSMIDRELRKRLDFLGYADQHYRDALTEVPHVDGDTAAERRAREVTYLALTRWAPTHLDRADRMSMAHGVQLRPPFCDRALVEYVYNVPAAMKRVDGVEKSLLRSAVADLLPDEVLHRRKSAYPTTQEAAYGDFVRQRFAELAADRDAAVAELLDTTATAEAVAADGSPQGAFAWVERAGMEMALQLDTWLTDYRVDLRL	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	130.48	gnl|BL_ORD_ID|729|hsp_num:0	796			1296	1413	rifampin; rifaximin; rifabutin; rifapentine
BGC0000230.1|Griseorhodin_17 # 19202 # 19573 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0000230.1|Griseorhodin_17 	19202	19573	+	Loose	150	23.0978	nimI	33.93	3007111	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGCACCGCACCCTGATCGTGGCCAGGATGAACCTGGCGGACGCCGAATGCGTCGGCAAGGTCTTCGCCGACTCGGACAGCACCGACCTGCCGCACATGGTGGGCGTCTCCCGGCGGACGCTGTTCGCCTTCCACGACCTGTACTTCCACCTCGTCGAGGCGGAGCAGGACATCAGCCCGAACCTCTACAAGGCCCGCAGCCACCCGCTGTACAACGACGTCAACACCCGGCTGCAGGAGTTCATCTCCCCCTACGACCCGGACTGGCGCGAGCCGCGCGACGCGATGGCCGTCCCGTTCTACTCGTGGACTCCGGAGAGCGGTCCCGTCATCACCCGGCCGGCCGCCCCGAACCTGGGCGGTGGCCGATGA	MHRTLIVARMNLADAECVGKVFADSDSTDLPHMVGVSRRTLFAFHDLYFHLVEAEQDISPNLYKARSHPLYNDVNTRLQEFISPYDPDWREPRDAMAVPFYSWTPESGPVITRPAAPNLGGGR	MNRLDNMEFREMRRKRQQLSDAECVGILENATSGTLALQGDGGYPYAVPISYVHADGKLYFHSALKGHKVDAIRGCDKASFCVIEQDEVHGEEYTPYFRSVIAFGRIRILEDEAERMAAARLLGDRYHPHHEEALGRELAKSFSHMLVICLDIEHMTGKEAIELVRMKRQRA	71.51	gnl|BL_ORD_ID|4788|hsp_num:0	5784			27	186	metronidazole
BGC0000230.1|Griseorhodin_18 # 19570 # 20004 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.740	BGC0000230.1|Griseorhodin_18 	19570	20004	+	Loose	875	25.0238	tet(O/M/O)	28.81	3007120	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACGACCGCGGCGGCCACCCCGGCCAAGGTCAACCTGGCGGAGGTCGCCCCCAACCGCAAGCGCGGCGGCGACATCCGCATCACCCTCAGCCCGCGCACGACCGGCTGCACCTCCGGGTTCGGCGGCACGCTGCGGCTGGAGGCGGGCGAGTACGTCACCGAGCACCTCCACCCGTACTCGGAGGAGTTCCTGCACGTCGTCACCGGCACGCTGGAGATCACCCTGGACGGCGCGCCCGTCGCCCTGGGCCCCGGCGACTCGCTGCTGGTCCCGATCAACATGCGCCACCGCCTGGTGAACACCGGGCCGGAGCCGGCGCAGGTCGTCTTCCACCTGTCGCCGCTCGCGCCCCGCCCGGAGCTGGGCCACGTCGACACCGAGGCCCCGCTCGACGGGAACGGCGCCAACCCCGACGTGGGGGGAGCGTCGTGA	MTTAAATPAKVNLAEVAPNRKRGGDIRITLSPRTTGCTSGFGGTLRLEAGEYVTEHLHPYSEEFLHVVTGTLEITLDGAPVALGPGDSLLVPINMRHRLVNTGPEPAQVVFHLSPLAPRPELGHVDTEAPLDGNGANPDVGGAS	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPMLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	22.54	gnl|BL_ORD_ID|4794|hsp_num:0	5790			1500	1677	tetracycline
BGC0000230.1|Griseorhodin_19 # 20001 # 21281 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGGGGG;rbs_spacer=6bp;gc_cont=0.740	BGC0000230.1|Griseorhodin_19 	20001	21281	+	Loose	750	179.489	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.98	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCCGACGCGCCGTCATCACGGGGATCGGAGCCGTCGCTCCCGGCGGCATCGGACGGGACGCGTACTGGGACCTGCTCGCGCACGGCCGTACGGCCACCCGGCGGATCAGCCGGTTCGACGCGTCGGCGTTCCGCTCGCAGGTCGCCGCCGAATGCGACTTCGACCCGGTCGCCGCGGGGCTGAGCCCGCAGGAAGTGCGCCGGATGGACCGGGCCGCCCAGTTCGCGGTGGTCGCGGCCCAGGAGGCGATCGAGGACAGCGGCATCGACGTCGGCGCGGGCGACCCGGGGCGGACCGCGGTCAGCATCGGCAGCGCGGTCGGCTGCACCACCGGCCTGGAGGACGAGTACGCGGTCCTCTCGGACGGCGGCCGGAACTGGCTGGTCGACCACACCTACGGGGTCCCGCACCTGTACGGCTACATGGTCCCCAGCACGCTGGCGGCCGAAGTGGCCTGGCGGGCGCGGGCGGAGGGCCCGGTGGCACTGATCTCGACCGGCTGCACCTCCGGTCTCGACGCGATCGCCCACGGCGTGCAGCTCATCGAGGAGGGCGCCGCCGACATCGTCCTGGCGGGCGCCACCGACGCCCCGCTGTCCCCCATCACCTCCGCCTGCTTCGACGCGATCAAGGCGACGACGCCCAACGCGGACCAGGACCCGGGCAGCGCCTCCCGCCCCTTCGACGGCCGCCGCGACGGCTTCGTGCTGGGCGAGGGCTCGGCGGTCATGGTGATCGAGGAGGCCGGGGCGGCCCGCCGCCGGGGGGCCACCGTCTACGCCGAGGTGGCCGGTTTCGCCAACCGCTCCAACGCCTTCCACATGACCGGGCTCAAGCCCGACGGGCGGGAGATGGCCGAGGCCATCCGGGTCGCCCTGGACCGCGCGCGGCTCGACCCCGGCGCGATCGACCACGTCAACGCGCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACGGCCGCCTTCAAGCGGTCCCTGGGGCAGCGCGCCCACGAGATCCCGGTCAGCTCCATCAAGTCGATGATCGGGCACTCCCTGGGGGCGATCGGCTCCCTGGAGGTGGCCGCCTGCGCCCTGGCGCTGCGCCACCAGGTGGTGCCGCCCACGGCGAACCTCACGGTCCCCGACCCCCAGTGCGACCTGGACTACGTCCCGGTCACCGCCCGGGAGCACCGCATGGACCACGTCCTCAGCGTCGGCAGCGGATTCGGCGGCTTCCAGAGCGCCATGATCCTCAGCCGGCCCGGAGCCCGTAAGGAGGCGGTCGCGTGA	MSRRAVITGIGAVAPGGIGRDAYWDLLAHGRTATRRISRFDASAFRSQVAAECDFDPVAAGLSPQEVRRMDRAAQFAVVAAQEAIEDSGIDVGAGDPGRTAVSIGSAVGCTTGLEDEYAVLSDGGRNWLVDHTYGVPHLYGYMVPSTLAAEVAWRARAEGPVALISTGCTSGLDAIAHGVQLIEEGAADIVLAGATDAPLSPITSACFDAIKATTPNADQDPGSASRPFDGRRDGFVLGEGSAVMVIEEAGAARRRGATVYAEVAGFANRSNAFHMTGLKPDGREMAEAIRVALDRARLDPGAIDHVNAHGSGTKQNDRHETAAFKRSLGQRAHEIPVSSIKSMIGHSLGAIGSLEVAACALALRHQVVPPTANLTVPDPQCDLDYVPVTAREHRMDHVLSVGSGFGGFQSAMILSRPGARKEAVA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.40	gnl|BL_ORD_ID|1968|hsp_num:0	1943			195	1245	isoniazid
BGC0000230.1|Griseorhodin_20 # 21278 # 22540 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.781	BGC0000230.1|Griseorhodin_20 	21278	22540	+	Loose	790	28.8758	mtrC	30.23	3000810	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGCGCTCGGCCTGCCCGCGGGGCGCCGCAGCCCGGCGGCCGTCACCGGCCTCGGCATCGTCGCCCCCACCGGCATCGGCGTCCGGCGGCACTGGGAGTCGGTGCTGGCCGGCAAGAGCGGCCTCGGCCGCATCACCCGCTTCGACCCGGCCGGCTACCCGGTCGAGGTGGCCGGGGAGGTGCCCGGCTTCACCGCGGGCGAGCAGGTGCCCCGGGGGCTGGTCGACCGGACCGACCGGTTCACCCACTTCGCCCTGGCCGCCGCCGAGGCGGCCCTCGCCGACGCGGACGCCGACCCGGCGCAGCTGCCCGAGTACGACATGGCCGTGGTCACCGCCGCCTCCTCCGGCGGCACCGAGTTCGGCCAGCACGAGATGGAGCGGCTCTACCAGCGGGGCCCGGCGTGGGTCGGCGCGTACCAGTCGATCGCCTGGTTCTACGCCGCCACCACCGGCCAGGTCTCCATCCGCCACGGCATGCGCGGCCCCTGCGGGGTCCTGTGCGCCGAACAGGCGGGCGGCCTGGACGCGTTGGGCCAGTCCCGGCGGCTGCTGGACACCGGCTCCCGGCTGGTGCTCAGCGGCGGCACGGACGCCTCGCTGTGCCCGTACGGGCTGACCGCCCAGCTGTCCACGGGGGCGCTGTCGGCCTCGGACGACCCGGCGCGGGCGTACCTGCCGTTCGACGAGGCCGCCGCCGGCTACGCGCCCGGGGAGGGCGGGGCCATGCTCCTCGTCGAGACCGAGCGCGGCGCGCGGGAGCGGGGGGTCCGCTCGTACGGCCGGATCCTCGGCTACGCGGCGGGGTTCGACCCGCCGTCCTCCTCCGGCCGCCCGCCCGTACTGGCCTCGGTCGTCCGCCGGGCGGTCGCGGACGCGGGGATCGGCGCGGACGCCGTGGACGTGGTCTTCGCCGACGCGGCGGGCACACCGGAGCTGGACCGTGCCGAGGCCGCCGCGATCAACGAGGTGTTCGGCGCCGGCCGGGTGCCGGTGACCGCGCCCAAGACCCTCACCGGGCGGCTGTACGCGGGCGGGGCCCCGCTCGACGTGGCGACCGCCCTGCTCGCCCTGTCCGCCGGCGTGATCCCGCACACCCCGGGCGTCGAACGCCCCGCGCCCGGCCTCGGCATCGACCTGGTCGTCGGCGGGCCGCGGCGGACCGGGGCCCGTACCGCCGTGGTGCTCGCCCGGGGTCACGGCGGGTTCACCTCCGCCCTGGTGGTCGAGGGGGGCGACCGAACCGACCACACCGCCTGA	MSALGLPAGRRSPAAVTGLGIVAPTGIGVRRHWESVLAGKSGLGRITRFDPAGYPVEVAGEVPGFTAGEQVPRGLVDRTDRFTHFALAAAEAALADADADPAQLPEYDMAVVTAASSGGTEFGQHEMERLYQRGPAWVGAYQSIAWFYAATTGQVSIRHGMRGPCGVLCAEQAGGLDALGQSRRLLDTGSRLVLSGGTDASLCPYGLTAQLSTGALSASDDPARAYLPFDEAAAGYAPGEGGAMLLVETERGARERGVRSYGRILGYAAGFDPPSSSGRPPVLASVVRRAVADAGIGADAVDVVFADAAGTPELDRAEAAAINEVFGAGRVPVTAPKTLTGRLYAGGAPLDVATALLALSAGVIPHTPGVERPAPGLGIDLVVGGPRRTGARTAVVLARGHGGFTSALVVEGGDRTDHTA	MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK	101.94	gnl|BL_ORD_ID|1232|hsp_num:0	1340			102	462	erythromycin; penicillin; azithromycin
BGC0000230.1|Griseorhodin_21 # 22603 # 23811 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000230.1|Griseorhodin_21 	22603	23811	+	Loose	450	70.4774	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	28.35	3004045	protein variant model	F203A	V78A:1574	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGCAGGCCACACGTCCAACTCCATCGTCATCGACGCCCCGATGGACCTCGTCTGGGAGCGCACGAACGACGTGGCGTCCTGGACCGAACTGTTCAGCGAGTACTCCCTCGCCGAGATCCTGGAGGAGGACGGCCCGACCGTCACCTTCCGGCTGGCCCTGCACCCGGACGAGAACGGGAAGGTGTGGAGCTGGGTCTCCCGGCGCACCACCGATGTGGCGTCCCGCACCGTCCGCGCCCACCGCGTCGAGACCGGCCCCTTCGCGTACATGAACATCCACTGGGAGTACGTCCAGACCGACGCGGGCGTCCGGATGCAGTGGACGCAGGACTTCCACATGAAGGACGAGGCCCCGATCGACGACGCGGGCATGACCGACCGCATCAACCGCAACAGCGTGGTCCAGATGGGTCTCATCAAGTCCAGGATCGAGGCCGCCGCCCGCGCGGCGCGCACCCCCTTCGCCGATCTGGCGGGCAAGCGGATCGTGGTCACGGGCGGCTCGCGGGGCATCGGGCGGGGCATCGTGCTCGCCGCCGCCCGGGCCGGCGCGGACGTGGTGACCTGCTACCGCGAGGAGAACGACCACACCGCGTCGCTGGCCAAGGAGCTGGCGCCGCTCCCGGGCTCGCAGCACCTGCTGCGGGCGGACGTGAGCGAGGCGGCCGGCGCCCGGCTGCTGGCGGACCGGGCGCGGGAGCTGCTCGGCGGGCTGGACGCGGTCGTCAACAACGCCGGCGACTTCGCGCCGCGGCCCTACACGGAGCTGACCGACGCGGCGTGGGCCACCGCGCTGCAGTCGAACCTGACCAGCACCCACCAGGTGATCCAGGCCGCCCTGCCGCTGCTGGGCGCGGGCGGGTCGATCGTCAACCTCGGCTCCACGGTGGCCCGTATCGGCATGGCCGGGGGCGTGCACTACACGGCGGTCAAGCAGGCCCTGGTCGGTCTGACCCGCTCGCTGGCCCGCGAGCTGGGGCCGCGCGGCATCCGGGTCAACACGCTCTCGCCGGGCCGCATCGCCACCGAGGCGCTCGACGCGCTGCCGCCCGAGGAGGCCGCCCGGCAGCGCGCGGTCTTCTCGAAGTTCGCCGCTCTCGGCCGGCTCGGCACCCCGCAGGAGATCGCGGACGTCGTGCTCTTCCTGATCAGCGACCAGTCCTCCTACATCACCGGACAGAACATCCACGTCGACGGCTGCGTGTGA	MAGHTSNSIVIDAPMDLVWERTNDVASWTELFSEYSLAEILEEDGPTVTFRLALHPDENGKVWSWVSRRTTDVASRTVRAHRVETGPFAYMNIHWEYVQTDAGVRMQWTQDFHMKDEAPIDDAGMTDRINRNSVVQMGLIKSRIEAAARAARTPFADLAGKRIVVTGGSRGIGRGIVLAAARAGADVVTCYREENDHTASLAKELAPLPGSQHLLRADVSEAAGARLLADRARELLGGLDAVVNNAGDFAPRPYTELTDAAWATALQSNLTSTHQVIQAALPLLGAGGSIVNLGSTVARIGMAGGVHYTAVKQALVGLTRSLARELGPRGIRVNTLSPGRIATEALDALPPEEAARQRAVFSKFAALGRLGTPQEIADVVLFLISDQSSYITGQNIHVDGCV	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	153.44	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	747	triclosan
BGC0000230.1|Griseorhodin_22 # 23808 # 24593 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000230.1|Griseorhodin_22 	23808	24593	+	Loose	450	79.337	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	27.52	3004045	protein variant model	F203L	V78A:1574	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGAGCCTCCGTCACCCCCTCGGAAAGGACAGGCCCGTGGAACTCGGACTGCAGGGAAAGAAGCTTCTGGTCACCGGGGGCTCCCGGGGCATCGGACGCGGCGTCGTGCTCGCCGCCGCCCGCGCCGGAGCCGACGTACTGACCTGCTACGTGAACGACAGCGAGCACGTCGAGAGCCTTCGCCGGGAGCTGAAGGCGCTCGGCGGCGACCACGAGGTCGTCCGGGCGGACGTGGGCGACCTGGACCAGGTCGACGCCCTGGTCGGGTGGGCCAGGGAGAGGTACGGCAAGCTCGACGGCATCGTCAACAACGCGGGCGTCATCAGCCACATACCGTTCGCCGAGCTCGCCCCCGACGAGTGGTCGCGCGTCCTGGACACCAACCTGACGGCCGCCTACCGCGTCATCCAGCAGTCGCTGCCGCTGCTCGGGTCCGGCGCCTCCGTCGTCAACATCGGTTCGCGCGGGGCCGCGGCCGGCATTCCGCTGCGCGCCCACTACACCGCCGCCAAGGCGGCCATGATCGGCCTGACCCGCTCGCTCGCCAAGGAGCTGGGCGGCAAGGGGATCCGGGTCAACGTGGTCGCCCCGGGCGTCATCGAAACCGAGGCGTTCGACACGATGCCCGCCGAGCGCGCGGAGGGGCTGCGGGCGATGTACGCGCAGAAGACCGCCCTGGCGCGGCTGGGCCGGGTCGACGAGCTGGCCGCGCCGGTCCTGTTCCTGCTCAGCGACCTCGCGGCGTACGTCACGGGCGAGACCCTCAACGTGGACGGGGGCATCTGA	MSLRHPLGKDRPVELGLQGKKLLVTGGSRGIGRGVVLAAARAGADVLTCYVNDSEHVESLRRELKALGGDHEVVRADVGDLDQVDALVGWARERYGKLDGIVNNAGVISHIPFAELAPDEWSRVLDTNLTAAYRVIQQSLPLLGSGASVVNIGSRGAAAGIPLRAHYTAAKAAMIGLTRSLAKELGGKGIRVNVVAPGVIETEAFDTMPAERAEGLRAMYAQKTALARLGRVDELAAPVLFLLSDLAAYVTGETLNVDGGI	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	99.62	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	753	triclosan
BGC0000230.1|Griseorhodin_23 # 24595 # 24918 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=8bp;gc_cont=0.688	BGC0000230.1|Griseorhodin_23 	24595	24918	+	Loose	2130	23.0978	mtrD	47.62	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTCCGACGCGACGTTCCGGGTGATGCTGCGCATGCAGATCAAGCCCGGCATGGAGGCCGACTTCGAGCGGGTGTGGAAGGAGGTCGGCGGCTCGGTCACCAGCGACCCGGCCAACCGGGGGCAGTGGCTGTCCCGGAGCACGACCGCCGACGAGGACGGCGTCTACTACATCATCAGCGACTGGGTGGACGAGCCGCAGTTCCGCCGGTTCGAGACCAGCGACACCCACCTGTCGCACCGCACCAAGCTGCATCCGTACCGCAGCGGCGGCTCCATGGCGACGATGGACATTGTCGCGAGCCTCTCCGGGGCGGCCGCGTGA	MSDATFRVMLRMQIKPGMEADFERVWKEVGGSVTSDPANRGQWLSRSTTADEDGVYYIISDWVDEPQFRRFETSDTHLSHRTKLHPYRSGGSMATMDIVASLSGAAA	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	10.03	gnl|BL_ORD_ID|1786|hsp_num:0	1938			642	705	erythromycin; penicillin; azithromycin
BGC0000230.1|Griseorhodin_24 # 24915 # 25223 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.718	BGC0000230.1|Griseorhodin_24 	24915	25223	+	Loose	575	23.8682	AST-1	33.33	3004740	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	AST Beta-lactamase	GTGACGGCCGCGCCCGCTGTGGAGGTGGTCCTCTACCACCTGTCCCCCAGCGGCGAGGACGTGCTGGCGGCCTACCACGAGGCCAGTCGCCGCATGGCGGGCACCCCGGGGCTGCTGGGCAACCAGCTGATGAGCGAGGTGGGCCGCCCGGACAGCTATGTGGTGGTCAGCCACTGGGACGCCTGGGAGTCCTTCGAGACGTGGGAGAGCGGCTCGGAGCACAAGGAGCAGACGGCGCCGCTGCGCGCGTTCCGCGACACCGAGCGGGCCCGCCCGTTCGAGATCTACCGGGTGCTCGCCGCCTACTGA	MTAAPAVEVVLYHLSPSGEDVLAAYHEASRRMAGTPGLLGNQLMSEVGRPDSYVVVSHWDAWESFETWESGSEHKEQTAPLRAFRDTERARPFEIYRVLAAY	MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELETTSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSAAELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDATSRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGATRIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAEATRVVVDALG	32.90	gnl|BL_ORD_ID|2556|hsp_num:0	3555			465	564	
BGC0000230.1|Griseorhodin_25 # 25315 # 26334 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.754	BGC0000230.1|Griseorhodin_25 	25315	26334	+	Loose	900	32.3426	lmrB	25.68	3002813	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGAGAGCCCGAGCCGTACGCACGACAGCACCACGGGCGCGCCGCCGCCCCCGGCCGAGCGGGCCGCGCGTCCGGCCGTGCGGGCTTCCCCGGGCCCCGGGGCCCGGCGGGCGTTCCTCACGCTGCTCGGCGTGGACCTGTGGGAGCGGTTCAGCTTCTTCGGGATGGCCGCGATCCTGGTGCTCTACCTCACCGCGGCGCCCGCAGACGGCGGCCTGGGCATGGCCCCGCAGACCGCCACCGCCGTGTTCGCCACGTACATGTCGTCGAGCTTCATCGCCGGGCTGCCCGGCGGCTGGCTGGCCGACCGGGTGCTGGGGGCGCGCCGGGCGGTGCTCGCGGGCGGCGGGCTCATCGCCGCCGGGCACGCGGTCCTCTCGCTCACGTCCGCCACCGCGCTCTACGCCGGGCTGCTCCTCATCGTCGTCGGCACCGGGCTGTCCAAGCCGTCGCTGGCCGCCATGGTGGCCGCCGTCAGCGGTCCGGAGCGGCGGGAGGCGGCGTTCTCACGCTTCTACATGTGCATCCAGGTCTCCGCGCTCGTCGCCCCCGTCGTCACCGGGCTGCTGGCCCAGCGGGTCGCCTGGCACCTCGGCTTTGCCGTGGCCGCCCTCGGTATGGCGGCGGGCCTGGCGCAGTTCGGCCTCGGGAATGCGCGCCTTCCCGGGACCGGCCCGGCCGGGACCCGATCACCTGTCCTGACTCACTTCACCTTCCGTACGGGAGAACACCATGGCCAAGAGCCGCAACAACCTCCTCGGCGTCGGCGGGCAGCGCAAGAAGCTGTCCCGCGCCGACCAGCAGGGCGCGGGCGCCGCACGCACCGCCGACCGCAAGGCCGCCGAGGACAAGAAGCAGGAGCTGGTGCGCAAGATGCGCGAGCGCGCCGAGGCGCAGGCGCCCGCCACCGCCGAGGCCGACGGGAACGCGACCGCCGCTCAGAGCTGACGCCCGAGCGGCGACGCGTCCGTACGACCGCGCACGCCACCCGCAGGACCGTGGGCCCGGATCACCCGTGA	MESPSRTHDSTTGAPPPPAERAARPAVRASPGPGARRAFLTLLGVDLWERFSFFGMAAILVLYLTAAPADGGLGMAPQTATAVFATYMSSSFIAGLPGGWLADRVLGARRAVLAGGGLIAAGHAVLSLTSATALYAGLLLIVVGTGLSKPSLAAMVAAVSGPERREAAFSRFYMCIQVSALVAPVVTGLLAQRVAWHLGFAVAALGMAAGLAQFGLGNARLPGTGPAGTRSPVLTHFTFRTGEHHGQEPQQPPRRRRAAQEAVPRRPAGRGRRTHRRPQGRRGQEAGAGAQDARARRGAGARHRRGRRERDRRSELTPERRRVRTTAHATRRTVGPDHP	METTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTGYLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTGLLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPFLVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVSLIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQGGLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTTSTAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAVSIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH	71.07	gnl|BL_ORD_ID|540|hsp_num:0	592			342	564	
BGC0000230.1|Griseorhodin_26 # 26369 # 26677 # -1 # ID=1_26;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000230.1|Griseorhodin_26 	26369	26677	-	Loose	1000	27.335	efpA	30.99	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	CGGGAGCAGCGGGTCTCCGTGGCCTGGCTGATCGGGGTGTACCTGCTCTACTCCCTCGGCGAGATCGTCCTCGCCCCGGCCGGGCTGGCGCTCGCGGCGGCGGTCGCCCCGCCCGGCTTCGCCAACCGCTTCCTCGCGCTCAACGGCATGTTCGCGGCGGTGGGCGTGGTGCTGGGCGGGCAGCTCTACCGGCTGACCTCGGTACTTCCGCTGCCCGTCTACTTCCTGCTGATGGGTACGGCCGTCCTGGCGATCGGCGCCGCCCTGGCGGCCCGCGCGCCACGGCTGCGGCCGGCGCTGCCGGAGTGA	REQRVSVAWLIGVYLLYSLGEIVLAPAGLALAAAVAPPGFANRFLALNGMFAAVGVVLGGQLYRLTSVLPLPVYFLLMGTAVLAIGAALAARAPRLRPALPE	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	19.25	gnl|BL_ORD_ID|2188|hsp_num:0	2427			402	615	rifampin; isoniazid
